ReviewCNS drugs2022

Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?

Anastasia Geladaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.